These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32996429)

  • 21. Artificial Pancreas Technology Offers Hope for Childhood Diabetes.
    Schoelwer MJ; DeBoer MD
    Curr Nutr Rep; 2021 Mar; 10(1):47-57. PubMed ID: 33411096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated insulin delivery systems: from early research to routine care of type 1 diabetes.
    Renard E
    Acta Diabetol; 2023 Feb; 60(2):151-161. PubMed ID: 35994106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions.
    Templer S
    Front Endocrinol (Lausanne); 2022; 13():919942. PubMed ID: 35733769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.
    Fuchs J; Hovorka R
    Expert Rev Med Devices; 2020 Jul; 17(7):707-720. PubMed ID: 32569476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated Insulin Delivery in Adults.
    Boughton CK; Hovorka R
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):167-178. PubMed ID: 31980116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
    Uduku C; Oliver N
    Curr Opin Pharmacol; 2017 Oct; 36():29-33. PubMed ID: 28802779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Artificial pancreas: where are we in 2020 ?].
    Radermecker RP
    Rev Med Suisse; 2020 Aug; 16(703):1494-1497. PubMed ID: 32852170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.
    Kahkoska AR; Mayer-Davis EJ; Hood KK; Maahs DM; Burger KS
    Diabet Med; 2017 Nov; 34(11):1500-1507. PubMed ID: 28626906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closed-loop insulin delivery for treatment of type 1 diabetes.
    Elleri D; Dunger DB; Hovorka R
    BMC Med; 2011 Nov; 9():120. PubMed ID: 22071283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.
    Infante M; Baidal DA; Rickels MR; Fabbri A; Skyler JS; Alejandro R; Ricordi C
    Artif Organs; 2021 Sep; 45(9):968-986. PubMed ID: 34263961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial Pancreas Project at Cambridge 2013.
    Hovorka R
    Diabet Med; 2015 Aug; 32(8):987-92. PubMed ID: 25819473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human-in-the-Loop Insulin Dosing.
    Bequette BW
    J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sub-cutaneous closed-loop: continuous glucose measurement and external insulin pump: hope in treatment of type 1 diabetes].
    Puech-Bret N; Hanaire H
    Ann Endocrinol (Paris); 2007 Jun; 68 Suppl 1():21-7. PubMed ID: 17961657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY; Haviland N; Bailey TS
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advancements in noninvasive glucose monitoring and closed-loop management systems for diabetes.
    Ma R; Shao R; An X; Zhang Q; Sun S
    J Mater Chem B; 2022 Jul; 10(29):5537-5555. PubMed ID: 35829706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.